GlaxoSmithKline News

A boy gets his shot of swine flu vaccine at a Vancouver clinic Monday. The federal government is preparing to ship 1.8 million more doses of the H1N1 vaccine to the provinces.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 10/30/09, Gilead Sciences, Inc.

On H1N1, Canada is a jurisdictional mishmash Four-year-old Rowan Watchmaker looks on as her mother is injected with the H1N1 flu vaccine at a clinic in Ottawa.

Today, ViiV Healthcare, a new specialist HIV company established by GlaxoSmithKline and Pfizer, was officially launched.

Systemic lupus is the most common form of the autoimmune disease, lupus , which afflicts about five million people worldwide and causes a slew of symptoms including fever, pain and swelling.

GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 FDA Review Date to February 9, 2010 Submitted by admin on 11/6/2009 @ 6:15 PM Companies mentioned in this article: XenoPort, Inc.

The U.S. Department of Health and Human Services today announced contract awards for up to 120,000 treatment courses of intravenous antiviral drugs to help treat hospitalized 2009 H1N1 influenza patients.

Antigenics, Inc. today indicated that GlaxoSmithKline's Phase III malaria vaccine clinical trial, containing Antigenics' QS-21 Stimulon adjuvant, has enrolled more than 5,000 children to date and is expected to involve up to 16,000 children.

Main Category: HIV / AIDS Also Included In: Pharma Industry / Biotech Industry Article Date: 04 Nov 2009 - 6:00 PST "GSK was at the forefront of breakthroughs in HIV and AIDS treatments in the late 1980s and 1990s with anti-virals such as Retrovir, Epivir and Combivir , which slow the effects of the illness.

Human Genome Sciences and GlaxoSmithKline said Monday their experimental lupus treatment passed another key goal on its path to potentially becoming the first new drug for the disease in decades.

Vaccine maker. Federal health officials are questioning whether it's in the public's best interest that Mississauga drug maker GlaxoSmithKline has the monopoly on the H1N1 flu vaccine.

The Lupus Research Institute and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta , the first successfully tested new drug developed specifically for people with systemic lupus.

GlaxoSmithKline and Pfizer announced November 3 the launch of ViiV Healthcare, a collaboration between both pharmaceutical companies' HIV drug divisions.

Synta Pharmaceuticals Corp. booked a profit and revenue increase in the most-recent quarter due to the accelerated receipt of payments from a partnership with GlaxoSmithKline .

After three weeks of getting over 700,000 H1N1 vaccines a week, Ontario this week will only have some 276,300 doses to administer in the fight against the potentially deadly virus.

The pharmaceutical companies GlaxoSmithKline and Pfizer announced today that the joint venture created by the merger of their HIV divisions is called ViiV Healthcare.

A mother watched with dread as a nurse inserted a tube in her baby's head. Blood streamed into the anemic 4-month-old who already has malaria, the mosquito-borne disease that kills a million African children every year.

Jacob Wong, 4, is comforted by his mother Johanna Wong as he reacts to getting the H1N1 flu vaccination at a clinic at Metro Hall in Toronto, Ontario, Nov.

The company making Canada's H1N1 vaccine has finished producing a special version of the shot for pregnant women and is again focusing its efforts on the vaccine intended for the majority of Canadians, a spokeswoman said Tuesday.

Main Category: Lupus Also Included In: Clinical Trials / Drug Trials Article Date: 03 Nov 2009 - 0:00 PST Human Genome Sciences and GlaxoSmithKline announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA for treating systemic lupus .